|
|
|
|

|
|
Back to List |
|
Reiter Syndrome |
|
Background:
Hippocrates observed that "A youth
does not suffer from gout until after sexual
intercourse." Medical observers over several
centuries clearly have been impressed by the
relation between sexually acquired genital
infections and the development of arthritis.
The first report in the English
literature of the classic triad of this entity
associated with a postvenereal prodrome was by Sir
Benjamin Brodie in 1818 (5 cases).
In 1916, Hans Reiter reported
the case of a young soldier who suffered from an
acute febrile illness that included purulent
conjunctivitis, nongonococcal urethritis, and
severe arthritis following an episode of bloody
diarrhea. The first case of a preadolescent with
the same symptoms was reported in 1947. In 1969,
the term reactive arthritis was proposed because
of the frequent association between enteric and
venereal infections and the subsequent development
of Reiter syndrome (RS).
The classic triad of arthritis,
urethritis, and conjunctivitis occurs in
approximately one third of patients at onset. The
less stringent American College of Rheumatology
criteria require a one month duration of arthritis
in association with urethritis and/or cervicitis.
These criteria have an 84.3% sensitivity and 98.2%
specificity in differentiating RS from gonococcal
arthritis, seronegative rheumatoid arthritis,
ankylosing spondylitis, or psoriatic arthritis.
Pathophysiology:
Although the cause of RS
has not been established, the association of RS
with some infectious agents in the GI or urinary
tract has been documented in many children and
adults. Gram-negative GI tract infections are the
most commonly reported organisms in children. Most
cases in adults, however, are mainly secondary to
venereal disease. The commonly reported
microorganisms are Salmonella, Shigella,
Yersinia, Campylobacter, Chlamydia, Mycoplasma,
and Ureaplasma species. HIV infection in
association with RS has been reported. However,
less than 4% of those infected with the above
noted organisms develop the symptom complex of RS.
The simultaneous occurrence of
RS in children and their parents suggests that
similar etiologic factors are important. Genetic
carriage of human leukocyte antigen (HLA)-B27 in
RS has been studied and is present in 67-92% in
pediatric cases (varies with the frequency of the
gene in the population at risk). Although the role
of HLA-B27 in disease pathogenesis remains
unknown, mechanisms of interplay may exist between
the microorganism and the gene. HLA-B27 might
affect immune mechanisms other than classical
antigen presentation, yet the mechanism by which
HLA-B27 confers susceptibility remains unknown.
Indeed, RS does not develop in all family members
who have diarrhea and carry HLA-B27; conversely,
RS may develop in a family without carriage of
HLA-B27 antigen, suggesting involvement by other
unknown factors in RS pathogenesis. Disease
penetrance of less than 50% has been found in
studies of monozygotic twins. There is less than a
1% risk of an HLA-B27 positive person actually
developing RS.
Frequency:
- In the US:
Overall (in adults and
children) estimated at between 3.5 and 5 per
100,000 males.
- Internationally:
RS is relatively
infrequent in children, and its true frequency
in childhood is difficult to determine. In a
report of 344 cases of postdysenteric RS, only
1% occurred in children. Several possible
reasons may explain why childhood RS rarely has
been documented, including the following:
- RS usually is not included
in the differential diagnosis of arthritis in
children.
- Diagnosis of dysuria and
urethritis in young children is difficult, as
is differentiating conjunctivitis from other
causes.
- Most cases are sporadic.
- The disease may occur over
a relatively short period, either in a single
family or as multiple cases in geographic
proximity.
Mortality/Morbidity:
The presence of
HLA-B27 is a major determinant of disease severity
and a predictor of recurrence. RS in a young child
or adolescent carrying HLA-B27 often is associated
with a recurrent arthritis and a more severe
course of the disease (eg, risk of sacroiliitis,
acute iridocyclitis). In many ways, the disease
course nearly mirrors juvenile ankylosing
spondylitis.
Race:
Patients with RS have been
described in all ethnic groups; no ethnic
predisposition is known.
Sex:
RS is most prevalent in boys. The
male-to-female ratio is 4:1 compared to the 50:1
ratio in adult venereal forms of RS.
Age:
Patients of all ages have been
reported, some as young as 2 years, although most
pediatric patients present with symptoms after age
9 years. The peak onset is in the third decade of
life.
History:
- Most children appear healthy
before the disease develops.
- Patients typically have no
unusual family history of rheumatic disease.
- Some patients may report a
history of diarrhea or sexual intercourse about
1-2 weeks prior to symptom onset. Diarrhea
precedes onset of RS in 70% of childhood cases.
- RS typically begins with
fever and diarrhea, followed by conjunctivitis
and then genitourinary, joint, and skin
symptoms. RS symptoms do not develop in a
consistent order.
- Initial symptoms may be
conjunctivitis, arthritis, and urethritis.
- The full classic triad (eg,
arthritis, urethritis, conjunctivitis) occurs
initially in only 35% of cases. All 3 major
symptoms usually develop within a 1- to 2-week
period, but all 3 occasionally manifest after 3
to 4 weeks. RS in children apparently has most
of the features seen in adult cases.
Physical:
The 4 major system
involvements are arthritis and enthesitis,
conjunctivitis, urethritis, and skin and
mucocutaneous lesions.
- Joint involvement is the
most prominent physical finding and the most
prolonged symptom of RS. This is the
presenting complaint in 25% of childhood
cases.
- Joints commonly are
described as tender, warm, swollen, and
sometimes red.
- Joint symptoms may present
initially or several weeks after onset of
other symptoms.
- Although these symptoms
usually are asymmetric and involve only a few
joints, migratory or symmetric involvement
also is reported.
- In childhood RS, the
patterns of joint involvement are 69%
oligoarticular or pauciarticular arthritis,
27% polyarticular, and 4% monoarticular.
Affected joints usually are the large
weight-bearing joints of the lower
extremities, although the upper extremities
may be involved.
- The most commonly involved
joints are the knee, ankle,
metatarsophalangeal, elbow,
metacarpophalangeal, hip, shoulder, and wrist.
Involvement of the fingers and toes may take
the form of dactylitis ("sausage digits").
- Sacroiliitis frequently
occurs in adults who are HLA-B27 positive but
appears to occur less often in children.
- At times, symptom severity
in involved joints fluctuates.
- Most symptoms are
self-limited and persist a few months.
- Arthritis usually is
remittent and rarely leads to severe
limitation of functional capacity.
- Enthesitis (ie,
inflammation of ligament and tendon insertions
into bone) is thought to be a characteristic
feature of RS and may be the predominant
complaint. The most common areas involved are
the insertions of (1) the Achilles tendon into
the calcaneus, (2) the plantar fascia into the
inferior surface of the calcaneus, (3) the
patellar ligament into the tibial tuberosity,
and (4) the quadriceps and patellar ligament
into the patella.
- Conjunctivitis is the most
frequent presenting complaint among children
(present in 2/3 of cases at onset). Typical
findings are bilateral, mucopurulent
conjunctivitis, which often varies from mild
to severe inflammation.
- Conjunctivitis may be
painless or may cause severe symptoms with
blepharospasm and photophobia.
- Conjunctivitis usually
resolves within 2 weeks.
- Other eye findings (eg,
iritis, keratitis, corneal ulceration, optic
neuritis) are reported more frequently in
children than in adults.
- Urethritis is difficult to
diagnose in children but is present in 30% of
childhood cases at onset.
- Obtaining a history of
dysuria in children is difficult, possibly
because it is mild or absent.
- In patients with painless
discharge, staining of the underpants may be
evident.
- The recommended procedure
is to conduct a careful historical and
clinical evaluation for urethritis, searching
for pyuria, meatal inflammation, and small
peri-meatal ulcerations.
- Balanitis and labial
ulcerations have been reported.
- Skin and mucocutaneous
lesions
- Skin and mucocutaneous
lesions are among the diagnostic criteria for
RS. Carefully search for mucocutaneous lesions
in patients for whom RS is suspected, although
these lesions occur less often in children.
- Keratoderma blennorrhagicum
is the distinctive and classic skin
manifestation of RS. The lesion begins as
macules and vesicles on the lateral aspects of
the palms and soles, progressing to
hyperkeratotic papules and plaques with a
pustular center. Most lesions usually occur on
weight-bearing or pressure areas of the soles
and palms, as well as on extensor surfaces of
the legs and dorsal aspects of the hands and
feet. These findings confirm an RS diagnosis.
- Nonspecific maculopapular
erythematous rashes often occur in children
with RS.
- Other reported skin
findings include erythema nodosa,
psoriatic-appearing papules, erythematous
hyperkeratotic plaques, and nail changes
including onycholysis, subungual debris,
periungual pustules, and, rarely, pitting.
- Reported mucosal lesions
include palatal erosions, balanitis circinata
(ie, shallow, sharply demarcated serpiginous
ulcers in uncircumcised men and hyperkeratotic
plaques in circumcised men), and circinate
vulvitis in women. These lesions rarely occur
in children but strongly suggest RS.
- Other systemic features
include: Low-grade fever, weight loss, epistaxis,
pleuritic pain with pleural effusion,
lymphadenopathy, or splenomegaly
Causes:
See pathophysiology.
Other Problems to be
Considered:
Other form of reactive arthritis
Enthesitis
Gonococcal arthritis
Hyperostotic syndromes with cutaneous pustular
lesions
Immunotherapy/Immunization related arthropathy
Inflammatory bowel disease
Poststreptococcal reactive arthritis
Psoriatic arthritis
Spondyloarthropathy
Lab Studies:
- RS is diagnosed clinically by
proper history and physical examination. No
specific tests or markers exist for RS.
Indicators of inflammation are usually abnormal.
Nonspecific laboratory findings include the
following:
- Patients have mild
normocytic normochromic anemia, thrombocytosis,
and leukocytosis (to 20,000/mm3).
- ESR, total serum hemolytic
complement (CH50), and C3 levels are elevated.
ESR in the 50-60 mm/h range can remain
elevated from weeks to months. C1, C4, and C5
levels are normal. C1 inhibitor functional
assay (C1INH) and C2 levels may be elevated.
- HLA-B27 carriage occurs in
67-92% of pediatric cases.
- Pyuria: WBCs, RBCs, and
small amounts of protein are found on
urinalysis. Urine culture may test positive
for Chlamydia or Ureaplasma
species, although test results may be negative
if obtained several weeks after the onset of
symptoms.
- A stool culture obtained
soon after the onset of diarrhea may identify
enteric pathogens (eg, Salmonella,
Shigella, Yersinia species). Positive
results are higher in children than in young
adults or adolescents.
- Synovial fluid reveals
increased leukocytes in a range of
10,000-40,000/mm3, with
polymorphonuclear cells (37-98%) predominant.
Levels of CH50, C1INH, C4, C5, and C3 in
synovial fluid are elevated.
Imaging Studies:
- In patients with advanced RS,
radiographic findings have included
periarticular demineralization, osteopenia,
periostitis, bony erosion of peripheral joints,
bony erosion at sites of ligament insertions to
the bone, spur formation, syndesmophytes,
enthesitis, and sacroiliitis.
- MRI is more sensitive than CT
or scintigraphy at detecting sacroiliitis and
may be necessary for use in children who do not
usually exhibit sacroiliac symptoms. MRI is also
useful in assessing activity in the tendons and
entheses.
Histologic Findings:
Histopathologic
findings of the early cutaneous lesions are
essentially the same as for psoriasis. Early
lesions of keratoderma blennorrhagicum and
balanitis circinata feature a spongiform pustule
in the upper dermis. Later lesions of keratoderma
usually no longer contain spongiform pustules but
reveal the nonspecific findings of acanthosis,
hyperkeratosis, and parakeratosis.
Reiter cells, large macrophages
containing engulfed lymphocytes, polymorphonuclear
leukocytes, and, rarely, plasma cells, may be seen
in synovial fluid. These cells comprise less than
1% of the synovial fluid white blood cells. These
cells are found in the synovium, however,
extensive pannus formation is rare.
Medical Care:
- No specific therapy for RS is
indicated.
- Mild cases of RS may recover
spontaneously.
- Antibiotics may be needed to
treat infections.
- Maintenance of joint function
through physical activity, joint protection,
suppression of inflammation.
Consultations:
- Ophthalmology for evaluation
of patients with eye involvement
- Rheumatology for followup and
medical management.
- Physical and occupational
therapy for maintenance of function and gait.
Diet:
- No limitations unless on
steroid therapy.
Activity:
- Limited only by the
arthropathy.
Arthritis and enthesitis
Aspirin and other short- and
long-acting anti-inflammatory drugs (eg,
indomethacin, naproxen) improve articular
symptoms. In one report, a patient became
asymptomatic after 3 months' administration of
aspirin at 80 mg/kg/d divided qid; the dosage then
was reduced gradually and eventually discontinued.
A combination of nonsteroidal anti-inflammatory
drugs (NSAIDs) reportedly is effective for severe
cases. No published data suggest any nonsteroidal
agent is more effective or less toxic than others.
(Controlled treatment trials are difficult to
conduct with an uncommon disease.)
A short course of antibiotics
may be needed, based on the culture results;
however, treatment may not affect the course of
RS. Administration of longer-term antibiotics to
treat joint symptoms provides no established
benefits.
Varying success in treating
severe cases has been reported from administration
of other medications (eg, sulfasalazine,
methotrexate, etretinate, ketoconazole,
azathioprine, intra-articular steroid injections).
Conjunctivitis
Transient and mild
conjunctivitis usually is not treated. Mydriatics
and cycloplegics (eg, atropine) with topical
corticosteroids may be administered for acute
anterior uveitis.
Urethritis and
gastroenteritis
Antibiotics may be considered,
based upon the cultures used and their
sensitivity. In general, treat urethritis with a
7- to 10-day course of erythromycin or
tetracycline.
Mucocutaneous lesions
Only local care for mucosal
lesions is necessary. Topical steroids may be
needed for psoriasiform lesions. Hydrocortisone
2.5% cream is effective for balanitis circinata,
and salicylic acid 10% ointment is effective in
treating chronic keratoderma blennorrhagicum,
although either condition may heal without medical
treatment.
Drug Category: Analgesic and antiinflammatory
agents -- Aspirin and several NSAIDs are
available and have similar effectiveness in
treating symptoms.
Drug Name
|
Aspirin (Anacin, Ascriptin,
Bayer Aspirin, Bayer Buffered Aspirin) --
Short-acting anti-inflammatory agent with
rapid absorption in proximal GI tract.
Optimally effective only when stable serum
levels of 150-250 mcg/L are achieved after 3-5
d of treatment. Serum aspirin levels can be
checked after 5-10 d of treatment. Maximal
anti-inflammatory action generally is achieved
within 2-4 wk, with some further benefit
occurring up to 3 mo. |
| Adult Dose |
325-650 mg PO q4-6h; not to
exceed 4 g/d |
| Pediatric
Dose |
75-100 mg/kg/d PO divided qid;
administer with food to minimize gastritis
>40 kg: 8-12 tab of 325 mg; not to exceed 4
g/d
|
|
Contraindications |
Documented hypersensitivity;
liver damage, hypoprothrombinemia, vitamin K
deficiency, bleeding disorders, asthma; due to
association of aspirin with Reye syndrome, do
not use in children (<16 y) with
influenza-like illness |
|
Interactions |
Effects may decrease with
antacids and urinary alkalinizers;
corticosteroids decrease salicylate serum
levels; additive hypoprothrombinemic effects
and increased bleeding time may occur with
coadministration of anticoagulants; may
antagonize uricosuric effects of probenecid
and increase toxicity of phenytoin and
valproic acid; doses >2 g/d may potentiate
glucose lowering effect of sulfonylurea drugs
|
| Pregnancy |
D - Unsafe in pregnancy
|
|
Precautions |
May cause transient decrease in
renal function and aggravate chronic kidney
disease; avoid use in patients with severe
anemia, with history of blood coagulation
defects, or those taking anticoagulants;
during therapy, regularly question parents and
children about eating habits, abdominal pain
or diarrhea, tinnitus or subtle hearing loss,
behavioral changes, bruising, and epistaxis;
family education about potential complications
is essential |
Drug Name
|
Naproxen -- Short-acting
(Aleve, Anaprox) and long-acting (Naprosyn,
Naprelan) agent for relief of mild to moderate
pain. Inhibits inflammatory reactions and pain
by decreasing activity of cyclooxygenase,
which is responsible for prostaglandin
synthesis. |
| Adult Dose |
250-500 mg PO bid; may increase
to 1.5 g/d for limited periods (for Naprelan,
administer entire calculated dose qd)
|
| Pediatric
Dose |
10-20 mg/kg/d PO divided bid;
not to exceed 1250 mg/d (for Naprelan,
administer entire calculated dose qd)
|
|
Contraindications |
Documented hypersensitivity;
peptic ulcer disease; recent GI bleeding or
perforation; renal insufficiency |
|
Interactions |
Coadministration with aspirin
increases risk of inducing serious NSAID-related
adverse effects; probenecid may increase
concentrations and, possibly, toxicity of
NSAIDs; may decrease effect of hydralazine,
captopril, and beta-blockers; may decrease
diuretic effects of furosemide and thiazides;
may increase PT when taking anticoagulants, so
instruct patients to watch for signs of
bleeding; may increase risk of methotrexate
toxicity; phenytoin levels may be increased
when administered concurrently |
| Pregnancy |
B - Usually safe but benefits
must outweigh the risks. |
|
Precautions |
Category D in third trimester
of pregnancy; acute renal insufficiency,
interstitial nephritis, hyperkalemia,
hyponatremia, and renal papillary necrosis may
occur; patients with preexisting renal disease
or compromised renal perfusion risk acute
renal failure; leukopenia occurs rarely, is
transient, and usually returns to normal
during therapy; persistent leukopenia,
granulocytopenia, or thrombocytopenia warrants
further evaluation and may require
discontinuation; hepatic impairment may
require dose reduction |
Drug Name
|
Indomethacin (Indochron E-R,
Indocin) -- Rapidly absorbed; metabolism
occurs in liver by demethylation,
deacetylation, and glucuronide conjugation;
inhibits prostaglandin synthesis. |
| Adult Dose |
25-50 mg PO bid/tid
75 mg SR PO bid; not to exceed 200 mg/d
|
| Pediatric
Dose |
1-2 mg/kg/d divided PO bid/qid;
not to exceed 4 mg/kg/d or 150-200 mg/d
|
|
Contraindications |
Documented hypersensitivity; GI
bleeding or renal insufficiency |
|
Interactions |
Coadministration with aspirin
increases risk of inducing serious NSAID-related
adverse effects; probenecid may increase
concentrations and, possibly, toxicity of
NSAIDs; may decrease effect of hydralazine,
captopril, and beta-blockers; may decrease
diuretic effects of furosemide and thiazides;
may increase PT when taking anticoagulants, so
instruct patients to watch for signs of
bleeding; may increase risk of methotrexate
toxicity; phenytoin levels may be increased
when administered concurrently |
| Pregnancy |
B - Usually safe but benefits
must outweigh the risks. |
|
Precautions |
Category D in third trimester
of pregnancy; acute renal insufficiency,
hyperkalemia, hyponatremia, interstitial
nephritis, and renal papillary necrosis may
occur; increases risk of acute renal failure
in patients with preexisting renal disease or
compromised renal perfusion; reversible
leukopenia may occur—discontinue if leukopenia,
granulocytopenia, or thrombocytopenia
persists; may cause severe headache in the
first few days after initiation of therapy,
which usually subside with continued use;
adverse effect sometimes avoided by starting
at half dose for 3-4 d with subsequent
increase |
Drug Category: Antibiotics
-- Empiric antimicrobial therapy must be
comprehensive and should cover all likely
pathogens in the clinical setting. Antibiotic
selection should be guided by blood culture
sensitivity whenever feasible.
Drug Name
|
Erythromycin (Erythrocin, E.E.S,
E-mycin, Eryc) -- Inhibits bacterial growth,
possibly by blocking dissociation of peptidyl
t-RNA from ribosomes, causing RNA-dependent
protein synthesis to arrest; used to treat
staphylococcal, streptococcal, Mycoplasma
pneumonia, chlamydia infections.
|
| Adult Dose |
0.25-1 g PO q6h; not to exceed
4 g/d |
| Pediatric
Dose |
30-50 mg/kg/d PO divided tid/qid;
not to exceed 2 g/d |
|
Contraindications |
Documented hypersensitivity;
hepatic impairment |
|
Interactions |
Coadministration may increase
toxicity of theophylline, digoxin,
carbamazepine, cisapride, valproic acid, and
cyclosporine; may potentiate anticoagulant
effects of warfarin; coadministration with
lovastatin or simvastatin, increases risk of
rhabdomyolysis |
| Pregnancy |
B - Usually safe but benefits
must outweigh the risks. |
|
Precautions |
Caution in liver disease;
estolate formulation may cause cholestatic
jaundice; adverse GI effects are common
(administer doses pc); discontinue use if
nausea, vomiting, malaise, abdominal colic, or
fever occur |
Drug Name
|
Tetracycline (Sumycin,
Achromycin) -- Treats gram-positive and
gram-negative organisms, as well as
mycoplasmal, chlamydial, and rickettsial
infections. Inhibits bacterial protein
synthesis by binding with 30S and possibly 50S
ribosomal subunit(s). |
| Adult Dose |
250-500 mg PO q6h |
| Pediatric
Dose |
<8 years: Not recommended
>8 years: 25-50 mg/kg/d PO divided qid; not to
exceed 3 g/d
|
|
Contraindications |
Documented hypersensitivity;
severe hepatic dysfunction |
|
Interactions |
Bioavailability decreases with
antacids containing aluminum, calcium,
magnesium, iron, or bismuth subsalicylate; can
decrease effects of PO contraceptives, causing
breakthrough bleeding and increased risk of
pregnancy; tetracyclines can increase
hypoprothrombinemic effects of anticoagulants
|
| Pregnancy |
D - Unsafe in pregnancy
|
|
Precautions |
Photosensitivity may occur with
prolonged exposure to sunlight or tanning
equipment; reduce dose in renal impairment;
consider drug serum level determinations in
prolonged therapy; tetracycline use during
tooth development (ie, last half of pregnancy
through age 8 y) can cause permanent
discoloration of teeth; Fanconi-like syndrome
may occur with outdated tetracyclines |
Drug Category: Topical
agents -- Topical steroids or salicylic acid
may be needed to treat psoriasiform lesions.
Drug Name
|
Hydrocortisone (Cortaid,
Dermacort, Westcort, CortaGel) -- An
adrenocorticosteroid derivative suitable for
application to skin or external mucous
membranes; has mineralocorticoid and
glucocorticoid effects resulting in
anti-inflammatory activity. |
| Adult Dose |
1-2.5% cream; apply as thin
film to affected area 3-4 times/d |
| Pediatric
Dose |
1-2.5% cream; apply as thin
film to affected area 3-4 times/d |
|
Contraindications |
Documented hypersensitivity;
viral, fungal, and bacterial skin infections
|
|
Interactions |
None reported |
| Pregnancy |
C - Safety for use during
pregnancy has not been established.
|
|
Precautions |
Prolonged use, application over
large surface areas, application of potent
steroids, and occlusive dressings may increase
systemic absorption of corticosteroids and may
cause Cushing syndrome, reversible HPA axis
suppression, hyperglycemia, and glycosuria |
Drug Name
|
Salicylic acid (Kerasal
ointment) -- By dissolving intercellular
cement substance, produces desquamation of
horny layer of skin, while not affecting
structure of viable epidermis. |
| Adult Dose |
10% ointment; apply as thin
layer to affected area 1-2 times/d
|
| Pediatric
Dose |
10% ointment; apply as thin
layer to affected area 1-2 times/d
|
|
Contraindications |
Documented hypersensitivity;
not recommended for prolonged use in infants,
diabetics, and patients with impaired
circulation |
|
Interactions |
None reported |
| Pregnancy |
C - Safety for use during
pregnancy has not been established.
|
|
Precautions |
Avoid contact with mucous
membranes and eyes; immediately flush with
water for 15 min if contact with eyes or
mucous membranes occurs; avoid inhaling vapors |
Drug Category: Slow-acting
antirheumatic disease agents (SAARDs) -- Have
shown some efficacy in uncontrolled trials.
Drug Name
|
Sulfasalazine (Azulfidine,
EN-tabs) -- Conjugate of the salicylate
5-aminosalicylic acid and the sulfonamide
sulfapyridine (linked by an azo bond).
Sulfasalazine is primarily excreted in the
urine unchanged. Most of the 5-aminosalicylic
acid remains in the colon and is not absorbed.
Acts locally to decrease the inflammatory
response in the joints and systemically
inhibits prostaglandin synthesis and folate
metabolism. Two multicenter,
placebo-controlled trials have indicated
tolerability and some efficacy in Reiter's
patients. |
| Adult Dose |
1 g PO tid/qid initially;
followed by maintenance dose of 2 g/d PO
divided q6-12h |
| Pediatric
Dose |
<2 years: Not established
>2 years: 40-60 mg/kg/d PO divided tid/qid;
not to exceed 2 g/d when used as maintenance
|
|
Contraindications |
Documented hypersensitivity;
sulfa drugs, or any component and those
diagnosed with GI or GU obstruction.
|
|
Interactions |
Decreases effects of iron,
digoxin, and folic acid; conversely, increases
effect of oral anticoagulants, oral
hypoglycemic agents, and methotrexate
|
| Pregnancy |
B - Usually safe but benefits
must outweigh the risks. |
|
Precautions |
Caution in patients with renal
or hepatic impairment, blood dyscrasias, or
urinary obstruction. |
Further Outpatient Care:
- Long-term follow-up care is
essential to ascertain whether the course of RS
is benign.
- Physical and occupational
therapy to maintain function and gait.
In/Out Patient Meds:
- Antiinflammatory drugs such
as aspirin, naproxen, or indomethacin.
- Antibiotics such as
erythromycin or tetracycline.
- Topical agents such as
hydrocortisone or salicylic acid ointment.
- Long-acting antiinflammatory/immunomodulatory
agents such as sulfasalazine, methotrexate, or
azathioprine.
Deterrence/Prevention:
- Education on the prevention
of the spread of sexually-transmitted diseases
through the use of condoms has been associated
with a decrease in the occurrence rate.
Prognosis:
- The natural history of
reactive arthritis is extremely variable. RS in
most children appears to be a self-limited
condition with gradual resolution of symptoms
and signs over a period of months. Some patients
may experience exacerbations and remissions that
can persist from several weeks to several
months.
- The clinical course of RS
usually is considered benign and self-limited;
however, chronic arthritis with sacroiliac
abnormalities and corneal scarring has been
reported as a result of juvenile RS.
- The presence of HLA-B27 may
predict a more prolonged course and severe
outcome and should be ascertained in patients
with RS.
Patient Education:
- Discourage inactivity and
immobilization
- Encourage stretching
exercises and range of motion.
- Encourage compliance with
medications and activity.
- Provision of information to
adolescent patients on the prevention of
sexually-transmitted diseases (STDs) and the use
of condoms.
|
|
Back to List
|
|
|